OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0938-AV24         View EO 12866 Meetings	Received Date: 02/22/2024
Title: Contract Year 2025 Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, and Medicare Cost Plan Programs, and PACE (CMS-4205)
Agency/Subagency: HHS / CMS	Stage: Final Rule
Concluded Action: Consistent with Change	Concluded Date: 03/29/2024
Legal Deadline: Statutory	Economically Significant: No
Publication Date:	Unfunded Mandates: No
Major: Yes	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: Undetermined	Small Entities Affected:
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No